Inside epoxyeicosatrienoic acids and cardiovascular disease

Area of Science:

• Biochemistry
• Cardiovascular Physiology
• Pharmacology

Background:

• Epoxyeicosatrienoic acids (EETs), derived from arachidonic acid via cytochrome P450 (CYP) epoxygenases, play vital roles in cardiovascular homeostasis.
• EETs exhibit potent vasodilatory, anti-inflammatory, anti-platelet aggregation, pro-fibrinolytic, and anti-proliferative effects on vascular smooth muscle cells.

Purpose of the Study:

• To explore the role of EETs in cardiovascular homeostasis and hypertension.
• To evaluate the therapeutic potential of strategies that enhance EET levels or activity for hypertension treatment.

Main Methods:

• Review of existing literature on EET biosynthesis, metabolism, and function.
• Analysis of studies investigating EET analogs and soluble epoxide hydrolase (sEH) inhibitors in preclinical and clinical settings.

Main Results:

• Altered EET biosynthesis is implicated in hypertension pathophysiology.
• EET analogs and sEH inhibitors demonstrate vasodilatory, antihypertensive, and anti-inflammatory effects.
• Several agents targeting EET metabolism are in clinical trials for hypertension and diabetes.

Conclusions:

• Enhancing CYP-derived EET levels or activity presents a promising therapeutic avenue for hypertension.
• Potential limitations, including the role of CYP epoxygenases and their metabolites in cancer progression, warrant careful consideration for clinical application.